Healthcare
Live Price
Offline$4.29
-9.68% today
Window Change
-36.67%
Window
Dec 4, 2025 → Jun 17, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 133 bars · Dec 4, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Regentis Biomaterials Ltd. (RGNT) is a Healthcare stock with a market cap of $10.00M and listed on AMEX. The stock last traded around $4.29 and down 36.7% across the available one-year price window (Dec 4, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 0.0% and ROIC 0.0%. Stock Foundry combines RGNT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RGNT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RGNT Max Drawdown
-83.38%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RGNT and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
+0.0%
EPS Growth
+0.0%
Gross Margin
0.0%
Net Margin
0.0%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.